Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of sugammadex versus placebo for reversal of profound neuromuscular blockade in elective surgery
2008-002518-23Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial comparing Sugammadex 4.0 mg/kg with Placebo (2 arms). Primary endpoint: Time to recovery of T4/T1 ratio to 0.9. Started Jan 2009; status: completed.
02
Drugs
Sugammadex
Beyond the preview
Go deeper on 2008-002518-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002518-23.